Background Given that statins are increasingly being used for primary‐prevention, the public
concerns regarding the risk of new‐onset diabetes mellitus associated with statin use may …

Introduction Even though several landmark statin trials have demonstrated the beneficial
effects of statin therapy in both primary and secondary prevention of cardiovascular disease …

Objective Several clinical trials of cardiovascular disease prevention with statins have
reported increased risk of type 2 diabetes (T2DM) with statin therapy. However, participants …

Background Statin use is associated with increased incidence of diabetes and possibly with
increased body weight and reduced exercise capacity. Data on the long-term effects of these …

Objective: To identify and assess studies investigating the association between statins and
new-onset diabetes and determine the clinical significance of this risk. Data sources: A …

Background We evaluated the effect of statin use on new-onset type 2 diabetes among
individuals without atherosclerotic cardiovascular disease (ASCVD) using nationally …

Background Statins have been known to increase the risk of incident type 2 diabetes
mellitus (DM); however, other factors, especially hypertension, are also associated with DM …

Objectives: This study aimed to evaluate the association of statin exposure and incident
diabetes, and subsequent outcomes in the general population. Background: Cardiovascular …

Diabetes mellitus (DM), a modern-day epidemic, is a significant risk factor for cardiovascular
disease. It is believed that statins elevate the risk of incident DM. Multiple trials were …

Introduction Data suggest that the beneficial cardiovascular effects of statins are maximized
after the first year of statin use; yet, the timeline of statin-associated adverse events is not …